|
WO2011086194A1
|
|
Improved oral lysophilisates containing pvp/va
|
|
EP2359812A1
|
|
Oral lyophilised compositions
|
|
US2010080829A1
|
|
Lyophilized pharmaceutical compositions and methods of making and using same
|
|
EP2238973A1
|
|
Lyophilized preparations of proteasome inhibitors
|
|
EP2192121A1
|
|
Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
|
|
EP1980245A1
|
|
Bilayer lyophilized pharmaceutical compositions and methods of making and using same
|
|
EP1980240A1
|
|
Lyophilized pharmaceutical compositions and methods of making and using same
|
|
EP1905429A1
|
|
Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles
|
|
EP1891938A1
|
|
High dose orally dissolvable/disintegrable lyophilized dosage form
|
|
IL174153D0
|
|
Process for enantioselective synthesis of single enantiomers of modafinil and its derivatives by asymmetric oxidation
|
|
US2006024370A1
|
|
Modafinil oral lyophilizate
|
|
US2005282821A1
|
|
Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
|
|
US2005256133A1
|
|
Thio-substituted arylmethanesulfinyl derivatives
|
|
US2005222257A1
|
|
Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
|
|
EP1702915A1
|
|
Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
|
|
EP1621186A1
|
|
Modafinil oral lyophilizate
|
|
EP1589016A1
|
|
Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
|
|
EP1516869A1
|
|
Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
|
|
TW200413296A
|
|
Modafinil polymorphic forms
|
|
EP1477476A1
|
|
Modafinil synthesis process
|
